StockNews.com initiated coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a report published on Thursday morning. The brokerage issued a sell rating on the stock.
Separately, HC Wainwright lifted their price target on SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a report on Thursday, December 12th.
View Our Latest Analysis on SenesTech
SenesTech Trading Down 4.7 %
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Read More
- Five stocks we like better than SenesTech
- What is an Earnings Surprise?
- Jabil’s Winning Streak Begins: Market Bottom Set, Future in Focus
- Quiet Period Expirations Explained
- High-Flying HEICO Eyes New Heights in 2025
- 3 Warren Buffett Stocks to Buy Now
- Beyond Reality: Investing in AR/VR Tech for Future Gains
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.